Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VCN-01 |
Trade Name | |
Synonyms | |
Drug Descriptions |
VCN-01 is a replication-competent oncolytic adenovirus that may lead to decreased tumor cell viability and reduced tumor growth (PMID: 26603261), particularly in tumors with a dysfunctional RB1 pathway (PMID: 30674657). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C113790 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Durvalumab + VCN-01 | Durvalumab VCN-01 | 0 | 1 |
Gemcitabine + Nab-paclitaxel + VCN-01 | Gemcitabine Nab-paclitaxel VCN-01 | 0 | 1 |
HuCART-meso cells + VCN-01 | HuCART-meso cells VCN-01 | 0 | 1 |
VCN-01 | VCN-01 | 1 | 0 |